首页> 美国卫生研究院文献>Acta Naturae >N-Terminal Fusion Tags for Effective Production of G-Protein-CoupledReceptors in Bacterial Cell-Free Systems
【2h】

N-Terminal Fusion Tags for Effective Production of G-Protein-CoupledReceptors in Bacterial Cell-Free Systems

机译:N末端融合标签可有效生产G蛋白偶联蛋白细菌无细胞系统中的受体

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

G-protein-coupled receptors (GPCR) constitute one of the biggest families of membrane proteins. In spite of the fact that they are highly relevant to pharmacy, they have remained poorly explored. One of the main bottlenecks encountered in structural-functional studies of GPCRs is the difficulty to produce sufficient amounts of the proteins. Cell-free systems based on bacterial extracts fromE. colicells attract much attention as an effective tool for recombinant production of membrane proteins. GPCR production in bacterial cell-free expression systems is often inefficient because of the problems associated with the low efficiency of the translation initiation process. This problem could be resolved if GPCRs were expressed in the form of hybrid proteins with N-terminal polypeptide fusion tags. In the present work, three new N-terminal fusion tags are proposed for cell-free production of the human β2-adrenergic receptor, human M1 muscarinic acetylcholine receptor, and human somatostatin receptor type 5. It is demonstrated that the application of an N-terminal fragment (6 a.a.) of bacteriorhodopsin fromExiguobacterium sibiricum(ESR-tag), N-terminal fragment (16 а.о.) of RNAse A (S-tag), and Mistic protein fromB.subtilisallows to increase the CF synthesis of the target GPCRs by5–38 times, resulting in yields of 0.6–3.8 mg from 1 ml of thereaction mixture, which is sufficient for structural-functional studies.
机译:G蛋白偶联受体(GPCR)构成了最大的膜蛋白家族之一。尽管它们与药学高度相关,但对其探索仍然不多。 GPCR的结构功能研究遇到的主要瓶颈之一是难以产生足够量的蛋白质。基于E细菌提取物的无细胞系统。大肠菌细胞作为重组生产膜蛋白的有效工具备受关注。由于与翻译起始过程效率低有关的问题,无细菌表达系统中的GPCR生产效率通常较低。如果GPCR以具有N端多肽融合标签的杂合蛋白形式表达,则可以解决此问题。在目前的工作中,提出了三种新的N末端融合标签,用于无细胞生产人β2-肾上腺素能受体,人M1毒蕈碱型乙酰胆碱受体和人生长抑素受体5型。证明了N-来自西伯利亚杆菌(Exiguobacterium sibiricum)的细菌视紫红质的末端片段(6 aa)(ESR-tag),RNAse A的N末端片段(16o.®。)和来自B的Mistic蛋白。枯草杆菌糖通过下列途径增加靶GPCR的CF合成5–38倍,从1毫升的果仁中获得0.6–3.8毫克的产量反应混合物,足以进行结构功能研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号